The prostate cancer in the community of Madrid in 2000 I.- Incidence

To know the incidence in the year 2000 of prostate cancer in the Autonomous Community of Madrid and its breakdown by Health Areas. Study of histologically confirmed prostate cancer case reports and retrospective data acquisition for 2000 in the Autonomous Community of Madrid, both from Public and Pr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Actas urologicas españolas 2003-05, Vol.27 (5), p.323-334
Hauptverfasser: Herranz Amo, F, Arias Funez, F, Arrizabalaga Moreno, M, Calahorra Fernández, F J, Carballido Rodríguez, J, Diz Rodríguez, R, Herrero Payo, J A, Llorente Abarca, C, Martín Martínez, J C, Martínez-Piñeiro Lorenzo, L, Mínguez Martínez, R, Moreno Sierra, J, Rodríguez Antolín, A, Tamayo Ruiz, J C, Turo Antona, J
Format: Artikel
Sprache:spa
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 334
container_issue 5
container_start_page 323
container_title Actas urologicas españolas
container_volume 27
creator Herranz Amo, F
Arias Funez, F
Arrizabalaga Moreno, M
Calahorra Fernández, F J
Carballido Rodríguez, J
Diz Rodríguez, R
Herrero Payo, J A
Llorente Abarca, C
Martín Martínez, J C
Martínez-Piñeiro Lorenzo, L
Mínguez Martínez, R
Moreno Sierra, J
Rodríguez Antolín, A
Tamayo Ruiz, J C
Turo Antona, J
description To know the incidence in the year 2000 of prostate cancer in the Autonomous Community of Madrid and its breakdown by Health Areas. Study of histologically confirmed prostate cancer case reports and retrospective data acquisition for 2000 in the Autonomous Community of Madrid, both from Public and Private Health Care hospitals. Gross incidence of prostate cancer in the Autonomous Community of Madrid was 100.4 cases per 100,000 males. The incidence adjusted for the Spanish, European and Worldwide population was 120.1, 103.5 and 68.6 cases per 100,000 males, respectively. Mean age at diagnosis was 70 +/- 7.8 (40-94) years, median of 70 years. The age group with higher incidence was 70 to 79 years. The incidence of prostate cancer in the Autonomous Community of Madrid is lower than that in the US but higher than in most countries or regions in the EU. The different way of using PSA testing in the Health Areas of the Autonomous Community may explain the differences seen in terms of incidence by Area.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_73523194</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73523194</sourcerecordid><originalsourceid>FETCH-LOGICAL-p549-ac419608a88a4ef6ec32441fb9a23555a6cc9f4e5dae69c370bf44f9160321703</originalsourceid><addsrcrecordid>eNo1T7lOxDAUdAFil4VfQK7ogp7PxCVarkiLaNJHL86zMMqxxEmxf08QSzXSXJq5YFuQAjJdgN2w65S-AKRWRX7FNkIWTjhwW_ZUfRI_TmOacSbucfA08TjweaX92PfLEOcTHwN_x3aK7a8kAYCXDxkvBx9bWhM37DJgl-j2jDtWvTxX-7fs8PFa7h8P2dFol6HXwlkosChQU7DkldRahMahVMYYtN67oMm0SNZ5lUMTtA5OWFBS5KB27P6vdt37vVCa6z4mT12HA41LqnNlpBJOr8a7s3Fpemrr4xR7nE71_231A_FJUCg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73523194</pqid></control><display><type>article</type><title>The prostate cancer in the community of Madrid in 2000 I.- Incidence</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Herranz Amo, F ; Arias Funez, F ; Arrizabalaga Moreno, M ; Calahorra Fernández, F J ; Carballido Rodríguez, J ; Diz Rodríguez, R ; Herrero Payo, J A ; Llorente Abarca, C ; Martín Martínez, J C ; Martínez-Piñeiro Lorenzo, L ; Mínguez Martínez, R ; Moreno Sierra, J ; Rodríguez Antolín, A ; Tamayo Ruiz, J C ; Turo Antona, J</creator><creatorcontrib>Herranz Amo, F ; Arias Funez, F ; Arrizabalaga Moreno, M ; Calahorra Fernández, F J ; Carballido Rodríguez, J ; Diz Rodríguez, R ; Herrero Payo, J A ; Llorente Abarca, C ; Martín Martínez, J C ; Martínez-Piñeiro Lorenzo, L ; Mínguez Martínez, R ; Moreno Sierra, J ; Rodríguez Antolín, A ; Tamayo Ruiz, J C ; Turo Antona, J</creatorcontrib><description>To know the incidence in the year 2000 of prostate cancer in the Autonomous Community of Madrid and its breakdown by Health Areas. Study of histologically confirmed prostate cancer case reports and retrospective data acquisition for 2000 in the Autonomous Community of Madrid, both from Public and Private Health Care hospitals. Gross incidence of prostate cancer in the Autonomous Community of Madrid was 100.4 cases per 100,000 males. The incidence adjusted for the Spanish, European and Worldwide population was 120.1, 103.5 and 68.6 cases per 100,000 males, respectively. Mean age at diagnosis was 70 +/- 7.8 (40-94) years, median of 70 years. The age group with higher incidence was 70 to 79 years. The incidence of prostate cancer in the Autonomous Community of Madrid is lower than that in the US but higher than in most countries or regions in the EU. The different way of using PSA testing in the Health Areas of the Autonomous Community may explain the differences seen in terms of incidence by Area.</description><identifier>ISSN: 0210-4806</identifier><identifier>PMID: 12891909</identifier><language>spa</language><publisher>Spain</publisher><subject>Adult ; Age Distribution ; Aged ; Aged, 80 and over ; Humans ; Incidence ; Male ; Middle Aged ; Prostate-Specific Antigen - blood ; Prostatic Neoplasms - blood ; Prostatic Neoplasms - epidemiology ; Retrospective Studies ; Spain - epidemiology</subject><ispartof>Actas urologicas españolas, 2003-05, Vol.27 (5), p.323-334</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12891909$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Herranz Amo, F</creatorcontrib><creatorcontrib>Arias Funez, F</creatorcontrib><creatorcontrib>Arrizabalaga Moreno, M</creatorcontrib><creatorcontrib>Calahorra Fernández, F J</creatorcontrib><creatorcontrib>Carballido Rodríguez, J</creatorcontrib><creatorcontrib>Diz Rodríguez, R</creatorcontrib><creatorcontrib>Herrero Payo, J A</creatorcontrib><creatorcontrib>Llorente Abarca, C</creatorcontrib><creatorcontrib>Martín Martínez, J C</creatorcontrib><creatorcontrib>Martínez-Piñeiro Lorenzo, L</creatorcontrib><creatorcontrib>Mínguez Martínez, R</creatorcontrib><creatorcontrib>Moreno Sierra, J</creatorcontrib><creatorcontrib>Rodríguez Antolín, A</creatorcontrib><creatorcontrib>Tamayo Ruiz, J C</creatorcontrib><creatorcontrib>Turo Antona, J</creatorcontrib><title>The prostate cancer in the community of Madrid in 2000 I.- Incidence</title><title>Actas urologicas españolas</title><addtitle>Actas Urol Esp</addtitle><description>To know the incidence in the year 2000 of prostate cancer in the Autonomous Community of Madrid and its breakdown by Health Areas. Study of histologically confirmed prostate cancer case reports and retrospective data acquisition for 2000 in the Autonomous Community of Madrid, both from Public and Private Health Care hospitals. Gross incidence of prostate cancer in the Autonomous Community of Madrid was 100.4 cases per 100,000 males. The incidence adjusted for the Spanish, European and Worldwide population was 120.1, 103.5 and 68.6 cases per 100,000 males, respectively. Mean age at diagnosis was 70 +/- 7.8 (40-94) years, median of 70 years. The age group with higher incidence was 70 to 79 years. The incidence of prostate cancer in the Autonomous Community of Madrid is lower than that in the US but higher than in most countries or regions in the EU. The different way of using PSA testing in the Health Areas of the Autonomous Community may explain the differences seen in terms of incidence by Area.</description><subject>Adult</subject><subject>Age Distribution</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Humans</subject><subject>Incidence</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Prostate-Specific Antigen - blood</subject><subject>Prostatic Neoplasms - blood</subject><subject>Prostatic Neoplasms - epidemiology</subject><subject>Retrospective Studies</subject><subject>Spain - epidemiology</subject><issn>0210-4806</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1T7lOxDAUdAFil4VfQK7ogp7PxCVarkiLaNJHL86zMMqxxEmxf08QSzXSXJq5YFuQAjJdgN2w65S-AKRWRX7FNkIWTjhwW_ZUfRI_TmOacSbucfA08TjweaX92PfLEOcTHwN_x3aK7a8kAYCXDxkvBx9bWhM37DJgl-j2jDtWvTxX-7fs8PFa7h8P2dFol6HXwlkosChQU7DkldRahMahVMYYtN67oMm0SNZ5lUMTtA5OWFBS5KB27P6vdt37vVCa6z4mT12HA41LqnNlpBJOr8a7s3Fpemrr4xR7nE71_231A_FJUCg</recordid><startdate>200305</startdate><enddate>200305</enddate><creator>Herranz Amo, F</creator><creator>Arias Funez, F</creator><creator>Arrizabalaga Moreno, M</creator><creator>Calahorra Fernández, F J</creator><creator>Carballido Rodríguez, J</creator><creator>Diz Rodríguez, R</creator><creator>Herrero Payo, J A</creator><creator>Llorente Abarca, C</creator><creator>Martín Martínez, J C</creator><creator>Martínez-Piñeiro Lorenzo, L</creator><creator>Mínguez Martínez, R</creator><creator>Moreno Sierra, J</creator><creator>Rodríguez Antolín, A</creator><creator>Tamayo Ruiz, J C</creator><creator>Turo Antona, J</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200305</creationdate><title>The prostate cancer in the community of Madrid in 2000 I.- Incidence</title><author>Herranz Amo, F ; Arias Funez, F ; Arrizabalaga Moreno, M ; Calahorra Fernández, F J ; Carballido Rodríguez, J ; Diz Rodríguez, R ; Herrero Payo, J A ; Llorente Abarca, C ; Martín Martínez, J C ; Martínez-Piñeiro Lorenzo, L ; Mínguez Martínez, R ; Moreno Sierra, J ; Rodríguez Antolín, A ; Tamayo Ruiz, J C ; Turo Antona, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p549-ac419608a88a4ef6ec32441fb9a23555a6cc9f4e5dae69c370bf44f9160321703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>spa</language><creationdate>2003</creationdate><topic>Adult</topic><topic>Age Distribution</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Humans</topic><topic>Incidence</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Prostate-Specific Antigen - blood</topic><topic>Prostatic Neoplasms - blood</topic><topic>Prostatic Neoplasms - epidemiology</topic><topic>Retrospective Studies</topic><topic>Spain - epidemiology</topic><toplevel>online_resources</toplevel><creatorcontrib>Herranz Amo, F</creatorcontrib><creatorcontrib>Arias Funez, F</creatorcontrib><creatorcontrib>Arrizabalaga Moreno, M</creatorcontrib><creatorcontrib>Calahorra Fernández, F J</creatorcontrib><creatorcontrib>Carballido Rodríguez, J</creatorcontrib><creatorcontrib>Diz Rodríguez, R</creatorcontrib><creatorcontrib>Herrero Payo, J A</creatorcontrib><creatorcontrib>Llorente Abarca, C</creatorcontrib><creatorcontrib>Martín Martínez, J C</creatorcontrib><creatorcontrib>Martínez-Piñeiro Lorenzo, L</creatorcontrib><creatorcontrib>Mínguez Martínez, R</creatorcontrib><creatorcontrib>Moreno Sierra, J</creatorcontrib><creatorcontrib>Rodríguez Antolín, A</creatorcontrib><creatorcontrib>Tamayo Ruiz, J C</creatorcontrib><creatorcontrib>Turo Antona, J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Actas urologicas españolas</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Herranz Amo, F</au><au>Arias Funez, F</au><au>Arrizabalaga Moreno, M</au><au>Calahorra Fernández, F J</au><au>Carballido Rodríguez, J</au><au>Diz Rodríguez, R</au><au>Herrero Payo, J A</au><au>Llorente Abarca, C</au><au>Martín Martínez, J C</au><au>Martínez-Piñeiro Lorenzo, L</au><au>Mínguez Martínez, R</au><au>Moreno Sierra, J</au><au>Rodríguez Antolín, A</au><au>Tamayo Ruiz, J C</au><au>Turo Antona, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The prostate cancer in the community of Madrid in 2000 I.- Incidence</atitle><jtitle>Actas urologicas españolas</jtitle><addtitle>Actas Urol Esp</addtitle><date>2003-05</date><risdate>2003</risdate><volume>27</volume><issue>5</issue><spage>323</spage><epage>334</epage><pages>323-334</pages><issn>0210-4806</issn><abstract>To know the incidence in the year 2000 of prostate cancer in the Autonomous Community of Madrid and its breakdown by Health Areas. Study of histologically confirmed prostate cancer case reports and retrospective data acquisition for 2000 in the Autonomous Community of Madrid, both from Public and Private Health Care hospitals. Gross incidence of prostate cancer in the Autonomous Community of Madrid was 100.4 cases per 100,000 males. The incidence adjusted for the Spanish, European and Worldwide population was 120.1, 103.5 and 68.6 cases per 100,000 males, respectively. Mean age at diagnosis was 70 +/- 7.8 (40-94) years, median of 70 years. The age group with higher incidence was 70 to 79 years. The incidence of prostate cancer in the Autonomous Community of Madrid is lower than that in the US but higher than in most countries or regions in the EU. The different way of using PSA testing in the Health Areas of the Autonomous Community may explain the differences seen in terms of incidence by Area.</abstract><cop>Spain</cop><pmid>12891909</pmid><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0210-4806
ispartof Actas urologicas españolas, 2003-05, Vol.27 (5), p.323-334
issn 0210-4806
language spa
recordid cdi_proquest_miscellaneous_73523194
source MEDLINE; Elsevier ScienceDirect Journals; EZB-FREE-00999 freely available EZB journals
subjects Adult
Age Distribution
Aged
Aged, 80 and over
Humans
Incidence
Male
Middle Aged
Prostate-Specific Antigen - blood
Prostatic Neoplasms - blood
Prostatic Neoplasms - epidemiology
Retrospective Studies
Spain - epidemiology
title The prostate cancer in the community of Madrid in 2000 I.- Incidence
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T02%3A07%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20prostate%20cancer%20in%20the%20community%20of%20Madrid%20in%202000%20I.-%20Incidence&rft.jtitle=Actas%20urologicas%20espa%C3%B1olas&rft.au=Herranz%20Amo,%20F&rft.date=2003-05&rft.volume=27&rft.issue=5&rft.spage=323&rft.epage=334&rft.pages=323-334&rft.issn=0210-4806&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E73523194%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73523194&rft_id=info:pmid/12891909&rfr_iscdi=true